(Press-News.org) Colorectal cancer (CRC) is the second most common cause of death from cancer in the United States (US) and the most prevalent malignant tumor worldwide. CRC refers to cancer in the colon or rectum, the two parts that make up the large intestine. In the US, deaths from CRC in people under 55 have been increasing since the mid-2000s, highlighting the need for effective treatments.
New data published in The Journal of Immunology, reveal that cytokine-induced killer (CIK) cell therapy improved overall survival and progression-free survival of patients with CRC. CIK cell therapy uses the patient’s immune cells to target and destroy cancer cells. Patients who received CIK cell therapy with chemotherapy or surgery showed improved outcomes regardless of whether they had early or advanced stages.
“For advanced colorectal cancer, the prognosis has been rather pessimistic, and patients at stages II-III face a relatively high risk of recurrence and metastasis following surgery, with limited treatment options for these patients. CIK cell therapy could enhance the survival of patients with CRC compared to traditional therapies,” said Dr. Yi Zhang, Director of the Biotherapy Center at the First Affiliated Hospital of Zhengzhou University, who led the study.
Despite the positive outcomes of CIK cell therapy, some patients do not respond to the treatment. Researchers analyzed blood samples from patients to determine whether any biomarkers could predict who would respond well to CIK cell therapy. They found that CEA (carcinoembryonic antigen) levels in a patient’s blood could indicate whether they would benefit from CIK cell therapy. CEA is expressed in some CRC patients who undergo surgery and is considered an indicator of poor prognosis and disease recurrence. These results could pave the way for a simple blood test administered before treatment, which could improve patient survival.
“The long-term effects of CIK cell therapy for CRC patients had not been understood until now. The promising results of our study will hopefully facilitate the widespread adoption of cell therapies for treating malignant tumors, including CRC,” said Dr. Zhang.
This retrospective study followed two groups of patients after they received treatment. The CIK group that received CIK cell therapy with chemotherapy or surgery and the control group that received chemotherapy and/or surgery. Patients were enrolled in the study from 2008 to 2014 and were followed through January 2020. Researchers monitored both the time between the first treatment and when a patient’s disease worsened (progression-free survival) and the time between the first treatment and death (overall survival). Comparing the results of progression-free survival and overall survival within the CIK group, researchers investigated different biomarkers in patients’ blood that may be most relevant to predicting survival.
The researchers plan to continue this work by investigating the effects of combining CIK therapy with chemotherapy, radiotherapy, and immunotherapy in the treatment of CRC and by conducting prospective clinical studies to establish CIK cell therapy as a treatment for CRC.
The research article is available in The Journal of Immunology or you can read more on AAI News. Please send requests for a PDF copy of the research article to kpalmer@aai.org.
Requests for interviews with authors, The Journal of Immunology or the American Association of Immunologists can be made to kpalmer@aai.org.
About The American Association of Immunologists
The American Association of Immunologists (AAI) is one of the world’s largest organizations of immunologists and scientists in related disciplines. Our mission is to improve global health and well-being by advancing immunology and elevating public understanding of the immune system. AAI members are responsible for some of the most significant biomedical discoveries of the past century, including the development of life-saving cancer immunotherapies, antibody therapies, transplant technologies, and vaccines. We support scientists across the field of immunology through knowledge dissemination, community building, advocacy, and public outreach.
About The Journal of Immunology
The Journal of Immunology (The JI) publishes peer-reviewed manuscripts describing novel findings in all areas of experimental immunology, including both basic and clinical studies. The JI is owned by the American Association of Immunologists and published in partnership with Oxford University Press.
Contact Information
Katherine Palmer, MPH
Communications Manager
301-634-7823
kpalmer@aai.org
END
Cell therapy improves overall survival of patients with colorectal cancer
2025-06-24
ELSE PRESS RELEASES FROM THIS DATE:
Food packaging is a source of micro- and nanoplastics in food
2025-06-24
About this study: New research analyzes 103 scientific studies related to micro- and nanoplastics (MNPs) from food packaging and other food contact articles (FCAs). The normal and intended use of FCAs is a source of MNPs in foodstuffs. The full dataset is freely available through an interactive dashboard.
Zurich, Switzerland – [June 17, 2025] – In a new research article being published in npj Science of Food, scientists led by the Food Packaging Forum show that the normal and intended use of plastic food packaging and other food contact articles (FCAs), such as opening a plastic bottle or chopping on a plastic cutting board, ...
New study sheds light on the effectiveness of measures to solve the 'migration crisis'
2025-06-24
Migration agreements between “transit countries”, such as Turkey or Libya, and Europe have in recent years become the norm as emergency measures to try to stop irregular migration. In 2024, for example, Egypt received over 5 billion euros to improve its border security measures. This kind of initiatives follow as a model the agreement signed in 2016 between the European Union and Turkey to prevent refugees and migrants from entering the EU: the main narrative is that such deals help to reduce overall irregular migration to Europe.
A new study by researchers ...
Strategy to prevent age-related macular degeneration identified
2025-06-24
A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular degeneration, a leading cause of blindness in people over age 50. The WashU Medicine researchers and their international collaborators implicated problems with cholesterol metabolism in this type of vision loss, perhaps helping to explain the links between macular degeneration and cardiovascular disease, which both worsen with age.
The new findings — identified using human plasma samples and mouse models of macular degeneration — suggest that increasing ...
500 bird species face extinction within the next century
2025-06-24
Climate change and habitat loss could cause more than 500 bird species to go extinct in the next 100 years, researchers from the University of Reading have found.
Their study, published today (Tuesday, 24 June) in Nature Ecology & Evolution, reveals this number is three times higher than all bird extinctions recorded since 1500 CE. The extinction of vulnerable birds such as the bare-necked umbrellabird, the helmeted hornbill, and the yellow-bellied sunbird-asity would greatly reduce the variety of bird shapes and sizes worldwide, harming ecosystems ...
Genetic markers for depression reveal consistent patterns in psychiatric treatment outcomes
2025-06-24
ENNA, Italy, 24 June 2025 – In a comprehensive Genomic Press Thought Leaders Invited Review, researchers have synthesized findings from dozens of studies examining how genetic markers for mood disorders influence treatment outcomes and clinical features across major psychiatric conditions. The analysis reveals that while polygenic scores currently show modest predictive power, they demonstrate consistent patterns that could eventually contribute to more personalized psychiatric care.
Genetic Signatures Show Consistent Treatment Patterns
Professor Alessandro Serretti from Kore University of Enna analyzed evidence spanning ...
Deep-sea mining could harm remote ocean ecosystems
2025-06-24
Deep-sea mining in a remote part of the Pacific Ocean could harm ocean life including whales and dolphins, new research shows.
The Clarion Clipperton Zone (CCZ) of the Eastern Pacific is a vast area of deep ocean and seamounts.
A Canadian firm – The Metals Company – is planning to explore parts of the CCZ for polymetallic nodules.
In two new studies, researchers found whales and dolphins – including an endangered sperm whale – in the CCZ, and raise concerns about impacts on a wide range of marine species.
“We ...
Stanford researcher develops machine learning models to decode brain aging at cellular level
2025-06-24
STANFORD, California, USA, 24 June 2025 – In a comprehensive Genomic Press interview, Stanford University researcher Eric Sun reveals how machine learning is revolutionizing our understanding of brain aging at an unprecedented cellular resolution. Dr. Sun, who will establish his independent laboratory at MIT's Department of Biological Engineering and the Ragon Institute in 2026, represents a new generation of computational scientists transforming aging research through innovative machine learning approaches.
Breakthrough Discovery ...
AI shortens the development time of new materials
2025-06-24
Time-consuming testing and computer simulations are bottlenecks in the design of new materials. A thesis from the University of Gothenburg aims to develop an AI model that can efficiently determine the durability and strength of woven composite materials.
Whether it is a floorball stick or a wind turbine blade to be constructed - often different composite materials are used. Composite means mixing several different materials, e.g., carbon fiber and polymers, to achieve the desired balance between different properties such as weight, durability and flexibility of the product.
However, designing ...
Insulin on edge: Study identifies stress-triggered gene behind diabetes
2025-06-24
Stress does no one — not even your insulin-producing cells — any good.
Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages pancreatic β-cells — the cells responsible for insulin production and blood sugar control — pushing them toward dysfunction. The findings highlight a promising new target for early intervention in type 2 diabetes.
While many factors can contribute to type 2 diabetes, lifestyle, especially diet, plays a major role in its onset. Genetics matter, but poor eating habits can greatly ...
Wildlife forensic scientists develop new tool to detect elephant ivory disguised as legal mammoth ivory
2025-06-24
To save elephant populations from extinction, the international community banned the sale of their ivory — but selling mammoth ivory remains legal, and the two are difficult to tell apart, especially for non-experts. This leaves a possible loophole for sellers of poached ivory to exploit. Now stable isotope analysis could provide a cheap, rapid option to speed up sample screening and stop the sale of elephant ivory.
“Smugglers routinely use mixed shipments — an illegal wildlife product mixed with a legal one of similar appearance — to fool law enforcement,” said Dr Pavel Toropov ...